This research shows the need for broader screening for bronchiectasis in those with alpha-1 antitrypsin deficiency, suggesting better access to therapies.
There is heterogeneity of bronchiectasis within α₁-AT deficiency; hence, there is a need for broader screening strategies to ensure timely access to emerging therapies and inclusion in ongoing research efforts https://bit.ly/4nCZsxM.
No takes yet. Share an insight, caveat, or question.
Kang et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: